Mixed connective tissue disease with interstitial pneumonia in HTLV-1 carrier: case report and review of the literature

Clin Rheumatol. 2004 Dec;23(6):548-51. doi: 10.1007/s10067-004-0955-y.

Abstract

We report on a carrier of human T-lymphotropic virus type 1 (HTLV-1) who developed mixed connective tissue disease (MCTD). This patient suddenly manifested clinical symptoms and interstitial pneumonia ascribable to MCTD following long-term infection with HTLV-1. After initiation of oral prednisolone all manifestations quickly improved in parallel with a decrease in inflammatory reactions. In this patient HTLV-1 infection might have played an important role in the pathogenesis of MCTD. Since HTLV-1 can cause adult T-cell leukemia and HTLV-1-associated myelopathy, and also collagen diseases including MCTD, careful observation is necessary even in a carrier, particularly when autoantibodies are detectable in serum.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Carrier State / immunology
  • Female
  • HTLV-I Infections / complications*
  • HTLV-I Infections / immunology
  • Humans
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / immunology
  • Lung Diseases, Interstitial / virology*
  • Mixed Connective Tissue Disease / drug therapy
  • Mixed Connective Tissue Disease / immunology
  • Mixed Connective Tissue Disease / virology*
  • Prednisolone / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Prednisolone